1
0
0
(1 - 27 von 34
)
MSG lesions decrease body mass of suckling-age rats by ...American Physiological Society Journal
journals.physiology.org
von C Schoelch · · Zitiert von: 31 — Corinna Schoelch,; Thomas Hübschle,; Ingrid Schmidt, and; Barbara Nuesslein-Hildesheim. Corinna Schoelch. Max-Planck-Institut für Physiologische und Klinische ... von C Schoelch · · Zitiert von: 31 — Corinna Schoelch,; Thomas Hübschle,; Ingrid Schmidt, and; Barbara Nuesslein-Hildesheim. Corinna Schoelch. Max-Planck-Institut für Physiologische und Klinische ...
Interaction of genetic and environmental programming of the ...American Physiological Society Journal
journals.physiology.org
von I SCHMIDT · · Zitiert von: 64 — Schmidt, Ingrid, Corinna Schoelch, Thomas Ziska, Darius Schneider, Eckhart Simon, and Andreas Plagemann. Interaction of genetic and environmental ... von I SCHMIDT · · Zitiert von: 64 — Schmidt, Ingrid, Corinna Schoelch, Thomas Ziska, Darius Schneider, Eckhart Simon, and Andreas Plagemann. Interaction of genetic and environmental ...
A randomised Phase IIa trial of amine oxidase copper ...RePEc: Research Papers in Economics
ideas.repec.org
von PN Newsome · · Zitiert von: 3 — (Boehringer Ingelheim). Corinna Schoelch ... Schattenberg & Vlad Ratziu & Judith Ertle & Jasmin Link & Alison Mackie & Corinna Schoelch & Eric Lawitz, von PN Newsome · · Zitiert von: 3 — (Boehringer Ingelheim). Corinna Schoelch ... Schattenberg & Vlad Ratziu & Judith Ertle & Jasmin Link & Alison Mackie & Corinna Schoelch & Eric Lawitz,
Normalization of Prandial Blood Glucose and Improvement of ...diabetesjournals.org
diabetesjournals.org
von R Grempler · · Zitiert von: 34 — Corinna Schoelch;. Corinna Schoelch. 1Department of Metabolic Diseases, Boehringer Ingelheim GmbH and Co. KG, Biberach, Germany. Search for other works by ... von R Grempler · · Zitiert von: 34 — Corinna Schoelch;. Corinna Schoelch. 1Department of Metabolic Diseases, Boehringer Ingelheim GmbH and Co. KG, Biberach, Germany. Search for other works by ...
Phase I studies of the safety, tolerability, pharmacokinetics ...Wiley
dom-pubs.onlinelibrary.wiley.com
von A Jungnik · · Zitiert von: 18 — ... Corinna Schölch PhD,. Corinna Schölch PhD. Boehringer Ingelheim Pharma GmbH, Biberach, Germany. Search for more papers by this author … See all ... von A Jungnik · · Zitiert von: 18 — ... Corinna Schölch PhD,. Corinna Schölch PhD. Boehringer Ingelheim Pharma GmbH, Biberach, Germany. Search for more papers by this author … See all ...
Characterization of Adenosine-A1 Receptor ebsco
web.p.ebscohost.com
von C Schoelch · · Zitiert von: 52 — Corinna Schoelch, Johanna Kuhlmann, Matthias Gossel, Guenter Mueller, Claudia Neumann-Haefelin,. Ulrich Belz, Juergen Kalisch, Gabriele Biemer-Daub, ... › login
A Genome-Wide Association Study of Diabetic Kidney ...
pure.qub.ac.uk
von NR van Zuydam · · Zitiert von: 118 — Corinna Schölch. Biomarker & Bioanlysis, Head of Lab. Heike Zimdahl-Gelling Pharmacogenomics, Head of Lab. 2 Leif Groop. › files
NAFLD and NASH biomarker qualification in the LITMUS ...ScienceDirect.com
www.sciencedirect.com
von DGK Rasmussen · · Zitiert von: 21 — Elizabeth Shumbayawonda 13 , Andrea Dennis 13 , Corinna Schoelch 14 , Vlad Ratziu, Carla Yunis 17 , Patrick Bossuyt 18 , Morten Asser Karsdal 1. Show more. von DGK Rasmussen · · Zitiert von: 21 — Elizabeth Shumbayawonda 13 , Andrea Dennis 13 , Corinna Schoelch 14 , Vlad Ratziu, Carla Yunis 17 , Patrick Bossuyt 18 , Morten Asser Karsdal 1. Show more.
Safety, tolerability, pharmacokinetics and pharmacodynamics ...Clinical Diabetes and Endocrinology
clindiabetesendo.biomedcentral.com
von S Bianzano · · Zitiert von: 13 — Corinna Schölch & … Ulrike Gräfe-Mody. Show authors. Clinical ... Arvid Jungnik & Corinna Schölch. Boehringer Ingelheim Pharma GmbH ... von S Bianzano · · Zitiert von: 13 — Corinna Schölch & … Ulrike Gräfe-Mody. Show authors. Clinical ... Arvid Jungnik & Corinna Schölch. Boehringer Ingelheim Pharma GmbH ...
A randomised Phase IIa trial of amine oxidase copper ...Nature
www.nature.com
von PN Newsome · · Zitiert von: 3 — Jasmin Link, Alison Mackie & Corinna Schoelch. Texas Liver Institute, University of Texas Health, San Antonio, TX, USA. Eric Lawitz. Authors. von PN Newsome · · Zitiert von: 3 — Jasmin Link, Alison Mackie & Corinna Schoelch. Texas Liver Institute, University of Texas Health, San Antonio, TX, USA. Eric Lawitz. Authors.
An exploratory study investigating biomarkers associated ...Nature
www.nature.com
von I Campo · · Zitiert von: 3 — Wiebke Sauter, Carina Ittrich & Corinna Schoelch. Translational Pulmonary Science Center, Cincinnati Children's Hospital, Cincinnati, OH, USA. von I Campo · · Zitiert von: 3 — Wiebke Sauter, Carina Ittrich & Corinna Schoelch. Translational Pulmonary Science Center, Cincinnati Children's Hospital, Cincinnati, OH, USA.
Epithelial dysregulation in obese severe asthmatics with ...Europe PMC
europepmc.org
von JM Perotin · · Zitiert von: 22 — ... Corinna Schoelch, James P.R. Schofield, S. Scott, N. Sehgal, Marcus Sjödin ... Corinna Schoelch, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach ... von JM Perotin · · Zitiert von: 22 — ... Corinna Schoelch, James P.R. Schofield, S. Scott, N. Sehgal, Marcus Sjödin ... Corinna Schoelch, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach ...
Performance of non-invasive tests and histology for the ...Nottingham Repository
nottingham-repository.worktribe.com
von FE Mózes · Zitiert von: 60 — Corinna Schölch. Judith Ertle. Ramy Younes. Anouk Oldenburger. Harvey Coxson. Rachel Ostroff. Leigh Alexander. Hannah Biegel. Mette Skalshøi Kjær. Lea Mørch ... von FE Mózes · Zitiert von: 60 — Corinna Schölch. Judith Ertle. Ramy Younes. Anouk Oldenburger. Harvey Coxson. Rachel Ostroff. Leigh Alexander. Hannah Biegel. Mette Skalshøi Kjær. Lea Mørch ...
Phase I studies of the safety, tolerability, pharmacokinetics ...DOI
doi.org
von A Jungnik · · Zitiert von: 26 — Corinna Schölch PhD,. Corinna Schölch PhD. Boehringer Ingelheim Pharma GmbH, Biberach, Germany. Search for more papers by this author. von A Jungnik · · Zitiert von: 26 — Corinna Schölch PhD,. Corinna Schölch PhD. Boehringer Ingelheim Pharma GmbH, Biberach, Germany. Search for more papers by this author.
Safety, tolerability, pharmacokinetics and ...Gale
go.gale.com
von S Bianzano · · Zitiert von: 13 — ... Corinna Schölch and Ulrike Gräfe-Mody. Date: Aug. 15, From: Clinical Diabetes and Endocrinology(Vol. 7, Issue 1). Publisher: BioMed Central Ltd. Document ... von S Bianzano · · Zitiert von: 13 — ... Corinna Schölch and Ulrike Gräfe-Mody. Date: Aug. 15, From: Clinical Diabetes and Endocrinology(Vol. 7, Issue 1). Publisher: BioMed Central Ltd. Document ...
A variant within the FTO confers susceptibility to diabetic ...PLOS
journals.plos.org
von M Taira · · Zitiert von: 33 — ... Alexander Ehlgen, Martin Gerl, Jochen Huber, Corinna Schölch, Heike Zimdahl-Gelling at Boehringer-Ingelheim, Ingelheim, Germany.
An exploratory study investigating biomarkers associated ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von I Campo · · Zitiert von: 2 — Ilaria Campo , Federica Meloni , Martina Gahlemann , Wiebke Sauter , Carina Ittrich , Corinna Schoelch , Bruce C Trapnell , Abhya Gupta ...
A randomised Phase IIa trial of amine oxidase copper ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von PN Newsome · · Zitiert von: 2 — ... Corinna Schoelch , Eric Lawitz ; BI NASH Phase IIa trial team. Affiliations. 1 National Institute for Health Research, Birmingham ... von PN Newsome · · Zitiert von: 2 — ... Corinna Schoelch , Eric Lawitz ; BI NASH Phase IIa trial team. Affiliations. 1 National Institute for Health Research, Birmingham ...
An exploratory study investigating biomarkers associated ...Europe PMC
europepmc.org
von I Campo · · Zitiert von: 3 — ... Corinna Schoelch. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. Search articles by 'Corinna Schoelch' · Schoelch C ...
Characterization of adenosine-A1 receptor-mediated ...Europe PMC
europepmc.org
von C Schoelch · · Zitiert von: 50 — Corinna Schoelch · Johanna Kuhlmann · Matthias Gossel · Guenter Mueller · Claudia Neumann-Haefelin · Ulrich Belz · Juergen Kalisch · Gabriele Biemer-Daub. von C Schoelch · · Zitiert von: 50 — Corinna Schoelch · Johanna Kuhlmann · Matthias Gossel · Guenter Mueller · Claudia Neumann-Haefelin · Ulrich Belz · Juergen Kalisch · Gabriele Biemer-Daub.
Improved lipid profile through liver-specific knockdown of ...Journal of Lipid Research
www.jlr.org
von JF Rippmann · · Zitiert von: 9 — Corinna Schoelch. Corinna Schoelch. Footnotes. Affiliations. Department of Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co ... von JF Rippmann · · Zitiert von: 9 — Corinna Schoelch. Corinna Schoelch. Footnotes. Affiliations. Department of Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co ...
Online supplementary materials S1 Table 1
ora.ox.ac.uk
von NR van Zuydam · · Zitiert von: 118 — Corinna Schölch. Biomarker & Bioanlysis, Head of Lab. Heike Zimdahl-Gelling Pharmacogenomics, Head of Lab. 2 Leif Groop. › objects › download_file
TOFA induces cell cycle arrest and apoptosis in ACHN and ...Journal of Cancer
www.jcancer.org
von D He · · Zitiert von: 15 — Sebastian Kreuz, Corinna Schoelch, Leo Thomas. et al. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations ... › ...
The Combination of MR Elastography and Proton Density ...aau.dk
vbn.aau.dk
von S Alsaqal · · Zitiert von: 2 — ... Heiko G. Niessen, Corinna Schoelch, Christian Schultheis, Johan Vessby, Alkwin Wanders, Fredrik Rorsman, Charlotte Ebeling Barbier. › publications
a potential novel treatment for autoimmune diseases - PubMed
pubmed.ncbi.nlm.nih.gov
von FN Albach · · Zitiert von: 25 — Authors. Fredrik N Albach , Frank Wagner , Andreas Hüser , Julia Igel , David Joseph , James Hilbert , Corinna Schoelch , Steven J Padula , Jürgen Steffgen ... › ...
NAFLD and NASH biomarker qualification in the LITMUS ...Amsterdam UMC research portal
researchinformation.amsterdamumc.org
von DGK Rasmussen · · Zitiert von: 20 — ... Corinna Schoelch, Vlad Ratziu, Carla Yunis, Patrick Bossuyt, Morten Asser Karsdal. Epidemiology and Data Science (AMC) · APH - Methodology (AMC) · APH ... von DGK Rasmussen · · Zitiert von: 20 — ... Corinna Schoelch, Vlad Ratziu, Carla Yunis, Patrick Bossuyt, Morten Asser Karsdal. Epidemiology and Data Science (AMC) · APH - Methodology (AMC) · APH ...
Normalization of Prandial Blood Glucose and Improvement of ...CiNii
cir.nii.ac.jp
von R Grempler · · Zitiert von: 34 — Corinna Schoelch: Department of Metabolic Diseases, Boehringer Ingelheim GmbH and Co. KG, Biberach, Germany. André van Marle: BioFocus DPI, a Galapagos Company ... von R Grempler · · Zitiert von: 34 — Corinna Schoelch: Department of Metabolic Diseases, Boehringer Ingelheim GmbH and Co. KG, Biberach, Germany. André van Marle: BioFocus DPI, a Galapagos Company ...
Alle Infos zum Namen "Corinna Schölch"
sortiert nach Relevanz / Datum